GLABF (Gemina Laboratories) Other Current Liabilities: $-0.00 Mil (As of Oct. 2025)


What is Gemina Laboratories Other Current Liabilities?

Gemina Laboratories GLABF -27.59% Other Current Liabilities is $-0.00 Mil as of Oct. 2025. The stock has 2 warning signs investors should review.

Gemina Laboratories's other current liabilities for the quarter that ended in Oct. 2025 was $-0.00 Mil.

Gemina Laboratories's quarterly other current liabilities stayed the same from Apr. 2025 ($0.00 Mil) to Jul. 2025 ($0.00 Mil) but then declined from Jul. 2025 ($0.00 Mil) to Oct. 2025 ($-0.00 Mil).

Gemina Laboratories's annual other current liabilities increased from Jan. 2023 ($-0.00 Mil) to Jan. 2024 ($0.00 Mil) but then declined from Jan. 2024 ($0.00 Mil) to Jan. 2025 ($0.00 Mil).

Gemina Laboratories Other Current Liabilities Related Terms

Gemina Laboratories Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories Other Current Liabilities Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
Other Current Liabilities
1.69 -0.00 -0.00 0.00 0.00

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.00

Gemina Laboratories Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $-0.00 Mil mean?
Gemina Laboratories (GLABF) has a Other Current Liabilities of $-0.00 Mil as of Oct. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Gemina Laboratories.
Is Gemina Laboratories' Other Current Liabilities too high?
Gemina Laboratories' current Other Current Liabilities is $-0.00 Mil.
How does Gemina Laboratories' Other Current Liabilities compare to VRTX and REGN?
Gemina Laboratories' Other Current Liabilities of $-0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Gemina Laboratories. Gemina Laboratories's current Other Current Liabilities is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current Other Current Liabilities of $-0.00 Mil. The current Other Current Liabilities is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current Other Current Liabilities is $-0.00 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.